Diego Celli, MD

Interventional Cardiology Fellow @Texas_Heart via IM @UMiamiMedicine I Postdoctoral Research Fellowship @NorthwesternMed

[Matt Segar @MattSegar]

We’ve spent a lot of time updating this to work with all medical specialties.

Please retweet and share.

Completely free to use. Just create an account here: https://t.co/Ri813T6oB6

Lots of exciting updates to come!

[Texas Heart Institute @ Baylor College of Medicine @Texas_Heart]

@Texas_Heart & @BiVACOR are thrilled to announce the successful completion of the first-in-human implantation of the BiVACOR Total Artificial Heart as part of the U.S. FDA Early Feasibility Study: https://t.co/ffmMCs32pL

#HeartFailure #HeartDisease #Cardiology #MedTech

[Chelsea Amo Tweneboah, MD @catweneboah]

🎊🔊 A new CardioNerds episode is out ! Featuring the team from the Texas Heart Institute 🔊🎊

319: Caring for the Middle Child of Pulmonary Embolism

Listen to @IBalachandran @celli_md with ECPR provided by @BaylorCardio and editing by @catweneboah

https://t.co/bgjjBOdr1N

[Jay Giri @jaygirimd]

🧵 @InariMedical FLAME trial (largest ever high risk PE study) presented today @ACCinTouch #ACC23 by Mitch Silver!

Details in this thread below

[Diego Celli, MD @celli_md]

@SanjanaRaoMD @AmCollegeGastro @DrLiverPatty @JacksonHealth @UMiamiHealth You are a shining star

[Daniel Ambinder, MD @Dr_DanMD]

@CardioNerds #CNCR recording in progress!!

Learning a ton from @Texas_Heart fellows @IsabelBalachan1 @celli_md and @AmitGoyalMD

Hint: Prep for this episode by reviewing these 2 phenomenal tweetorials by @AkivaRosenzveig

1⃣https://t.co/2bPSme1PLA

2⃣https://t.co/arsJm3ifWJ

[Diego Celli, MD @celli_md]

@niru_krish @Texas_Heart Welcome home! Looking forward to having you.

[Diego Celli, MD @celli_md]

@ABIMcert Shameful!

[Diego Celli, MD @celli_md]

New beginnings at the @Texas_Heart

[Diego Celli, MD @celli_md]

@ja_ocejo @dominicandoc2 Que privilegio trabajar contigo hermano @ja_ocejo. Orgullosos de ti!

[Dan Kim @dan___kim]

Top 10 #POCUS Papers of 2021
These aren't necessarily the best papers from last year, but they were papers that caught our interest
#VanPOCUS22 @VancouverPOCUS

[Adithya Mathews MD, MBA @adithm13]

FDA approved Mavacamten for #HOCM treatment. A cardiac myosin inhibitor that specifically targets the source of obstructive HCM. The EXPLORER-HCM trial demonstrated benefit versus placebo. EF must be >55%. Problem is pricing: $89,500/year #cardioED #cardiotwitter #echofirst

[Boskey 🫀 @OneMoreDrPatel]

Superficial temporal artery access for PCI! Whaaaat.

#CardioTwitter
Not #radialfirst in this case!

https://t.co/8KqB0ar7DD

[Adithya Mathews MD, MBA @adithm13]

Today, 20 years ago, April 16, 2002, Dr Alain Cribier performed the first #TAVR via venous transseptal approach on a 57 year old male in France with cardiogenic shock with EF 12%. Goal was to live 30 more minutes; Patient lived 4 months and died from noncardiac reasons. #history

[Hatem Soliman Aboumarie, FRCP, FEACVI, FASE, FHEA @EchoSoliman]

Stetho = chest
Scope = see

Stethoscope can only hear and can't 'see', it's a stethophone!

#POCUS is the 'true' Stethoscope!

[Cory M. Tschabrunn @CMTschabrunn]

For any future #EPeeps consults for xenotransplantated hearts - here is a normal pig 12-lead ECG for reference!

[Diego Celli, MD @celli_md]

@divya_kondapi Fevers and severe sore throat

[Juliette Power @JuliettePower44]

🫀Pulmonary Arterial Hypertension 🫁

In this infographic for @CardioNerds Academy, we discuss diagnosis & management of PAH!

Thanks to
@GRamaniMD
@karanpdesai
@AmitGoyalMD

[Tony Breu @tony_breu]

An updated list of Cardiology MedTweetorials

https://t.co/3oWaRbZOQ0